Biomarin Pharmaceutical Inc SEC filings BMRN
Biomarin Pharmaceutical Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 2, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 2, 2026 |
| DEFA14A | Additional proxy material | Apr 8, 2025 | — |
| DEF 14A | Proxy statement | Apr 8, 2025 | May 20, 2025 |
| DEFA14A | Additional proxy material | Apr 9, 2024 | — |
| DEF 14A | Proxy statement | Apr 9, 2024 | May 21, 2024 |
| DEFA14A | Additional proxy material | Apr 11, 2023 | — |
| DEF 14A | Proxy statement | Apr 11, 2023 | — |
| DEFA14A | Additional proxy material | Apr 12, 2022 | — |
| DEF 14A | Proxy statement | Apr 12, 2022 | May 24, 2022 |
| DEFA14A | Additional proxy material | May 17, 2021 | — |
| DEFA14A | Additional proxy material | Apr 13, 2021 | — |
| DEF 14A | Proxy statement | Apr 13, 2021 | May 25, 2021 |
| DEFA14A | Additional proxy material | Apr 14, 2020 | — |
| DEF 14A | Proxy statement | Apr 14, 2020 | May 27, 2020 |
| DEFA14A | Additional proxy material | Apr 23, 2019 | — |
| DEF 14A | Proxy statement | Apr 23, 2019 | Jun 4, 2019 |
| DEFA14A | Additional proxy material | Apr 24, 2018 | — |
| DEF 14A | Proxy statement | Apr 24, 2018 | Jun 5, 2018 |
| DEFA14A | Additional proxy material | Apr 25, 2017 | — |
| DEF 14A | Proxy statement | Apr 25, 2017 | Jun 6, 2017 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2017 | Jun 6, 2017 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BMRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Novato, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1048477
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.